Canada is in discussions with the World Health Organization (WHO) and the United States about possible provision of Canada’s experimental Ebola vaccine for use in Africa, Reuters reported.
The US is also working on a vaccine and the WHO and governments involved will collectively decide whether to use either one in Africa, Greg Taylor, deputy chief public health officer of the Public Health Agency of Canada, was quoted as saying.
Canada has a small amount of the vaccine and would need four to six months to produce a large quantity, Taylor said. The government’s vaccine is separate from the treatment being developed by Canada’s Tekmira Pharmaceuticals Corp.
“We see this as a global resource, something we need to put on the global table… We’re looking to do that as fast as we can,” Taylor was quoted as saying.
The Ebola outbreak in West Africa has so far killed 1,013 people, mostly in Guinea, Liberia and Sierra Leone.
– Contact us at [email protected]